EX-10.1



 Exhibit 10.1 

April 15, 2016 
 Matthew Ros 

3 Pond View Place 
 Andover, MA 01810 

Dear Matthew: 
 It is my pleasure to extend to you this offer of
employment with Epizyme, Inc. (the “Company”). On behalf of the Company, I am pleased to set forth below the terms of your employment with the Company: 
  

	 	1.	Employment. You will be employed to serve on a full-time basis as the Company’s Chief Operating Officer, commencing on a date on or prior to May 16, 2016 as may be mutually agreed by you and the
Company (such date being the “Start Date”). As Chief Operating Officer, you will be responsible for such duties as are consistent with such position, plus such other duties as may from time to time be assigned to you by the Company. You
shall report to the President and Chief Executive Officer or such other person as the President and Chief Executive Officer may designate, and you agree to devote your full business time, best efforts, skill, knowledge, attention and energies to the
advancement of the Company’s business and interests and to the performance of your duties and responsibilities as an employee of the Company. You agree to abide by the rules, regulations, instructions, personnel practices and policies of the
Company and any changes therein that may be adopted from time to time by the Company. 

  

	 	2.	Base Salary. Your base salary will be at the rate of $15,833.33 per semi-monthly pay period (which if annualized equals $380,000), less all applicable taxes and withholdings, to be paid in
installments in accordance with the Company’s regular payroll practices. Such base salary may be adjusted from time to time in accordance with normal business practices and in the sole discretion of the Company. 


 

	 	3.	Discretionary Bonus. Following the end of each fiscal year and subject to the approval of the Company’s Board of Directors or a committee of the Board of Directors (the “Board”),
you may be eligible for a retention and performance bonus, based on your performance and the Company’s performance during the applicable fiscal year, as determined by the Company in its sole discretion. The bonus payable to you for 2016, if
any, will be prorated to reflect the portion of 2016 for which you served as Chief Operating Officer of the Company. Your target bonus is 40% of your annualized base salary. Such target bonus may be adjusted from time to time in
accordance with normal business practices and in the sole discretion of the Company. You must be an active employee of the Company on the date any bonus is distributed in order to be eligible for and to earn a bonus award, as it also serves as
an incentive to remain employed by the Company. 

  

	 	4.	 Equity. Subject to Board approval, on or after your Start Date you will receive a stock option
grant under the Company’s 2013 Stock Incentive Plan (the “Plan”) for the purchase of 173,438 shares of common stock of the Company at an exercise price per 










	 	
share equal to the fair market value of one share of Common Stock on the date of the grant as determined by the Company in its sole discretion. The stock option grant shall be subject to all
terms and other provisions set forth in the Plan and in a separate stock option agreement, including the vesting schedule. The stock option agreement will provide that the option will vest over a four-year period with the first quarter of the
underlying shares vesting on the first anniversary of the Start Date and the remaining three-fourths of the underlying shares vesting monthly in 36 equal monthly installments following the first anniversary of the Start Date until fully vested on
the fourth anniversary of the Start Date. 

 You may also be eligible for other grants of stock or stock options as determined
by and in the sole discretion of the Board. Nothing in this section shall affect your status as an employee at will, as set for below. 
  

	 	5.	Sign-on Bonus. You will also receive an additional one-time payment of $65,000 (the “Sign-on Bonus”) on the date of the Company’s first regularly scheduled payroll after the Start Date, less
all applicable taxes and withholdings. If you resign from the Company for any reason or no reason or are terminated by the Company for Cause on or prior to the first anniversary of the Start Date, you will be required to repay to the Company 100% of
the Sign-on Bonus ($65,000). Any amounts owed under this Section 5 as a result of the cessation of your employment with the Company shall be repaid within 60 days of the date you cease to be an employee of the Company, and the Company shall have the
right to offset such amounts against any amounts it owes you under this letter, the Company’s Executive Severance and Change in Control Plan or otherwise. For purposes of this letter, “Cause” shall mean (a) a good faith finding
by the Company that (i) you have failed to perform your assigned duties for the Company to the Company’s satisfaction and have failed to remedy such failure within 15 days following written notice from the Company notifying you of such
failure, (ii) you have engaged in dishonesty, willful misconduct or gross negligence, (iii) you have breached or threatened to breach this letter or terms of any restrictive covenants or confidentiality agreement or any similar agreement with
the Company or (iv) violated any policies or procedures of the Company, or (b) your conviction of, or your entry of a pleading of guilty or nolo contendere to, any crime involving dishonesty or moral turpitude or any felony. 


 

	 	6.	Benefits. You may participate in any and all benefit programs that the Company establishes and makes available to its employees from time to time, provided that you are eligible under (and subject to
all provisions of) the plan documents that govern those programs. Benefits are subject to change at any time in the Company’s sole discretion. 

  

	 	7.	Vacation. You will be eligible for a maximum of three (3) weeks of paid vacation per calendar year to be taken at such times as may be approved in advance by the Company. The number of vacation
days for which you are eligible shall accrue at the rate of 1.25 days per month that you are employed during such calendar year. Your accrual and use of vacation time will be pursuant to Company policy, as established and as may be modified in
the sole discretion of the Company from time to time. 


  
 - 2 - 









	 	8.	Invention, Non-Disclosure, Non-Competition and Non-Solicitation Obligations. In exchange for your employment with the Company pursuant to the terms and conditions herein, you hereby
acknowledge and affirm your obligations set forth in the enclosed Invention and Non-Disclosure Agreement to be executed for the benefit of the Company, which obligations remain in full force and effect and is a condition to your employment
with the Company. 

  

	 	9.	At-Will Employment. This letter shall not be construed as an agreement, either express or implied, to employ you for any stated term, and shall in no way alter the Company’s policy of employment
at-will, under which both the Company and you remain free to end the employment relationship for any reason, at any time, with or without cause or notice. Similarly, nothing in this letter shall be construed as an agreement, either express or
implied, to pay you any compensation or grant you any benefit beyond the end of your employment with the Company, except as otherwise explicitly set forth herein. This letter supersedes all prior understandings, whether written or oral,
relating to the terms of your employment. 

  

	 	10.	Severance Benefits. In recognition of your position with and value to the Company, and to provide you with assurance in the event of certain employment terminations, you have been selected to
participate in the Company’s Executive Severance and Change in Control Plan, as amended from time to time, a copy of which is enclosed with this letter. 


If this letter correctly sets forth the terms under which you will be employed by the Company, please sign and return to me, no later than April 18, 2016, the
enclosed duplicate of this letter, the Invention and Non-Disclosure Agreement. 
  

			
	Sincerely,
		
	 By:
	 	 /s/ Robert Bazemore

		 	 Robert Bazemore

		 	 President and Chief Executive Officer



 The foregoing correctly sets forth the terms of my at-will employment with Epizyme, Inc. I am not relying on any
representations other than those set forth above. 
  

					
	 /s/ Matthew Ros
	 		 	 April 15, 2016

	Matthew Ros	 		 	Date


  
 - 3 -